We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Core Laboratories to Post Q4 Earnings: Here's What to Expect
Read MoreHide Full Article
Core Laboratories Inc. (CLB - Free Report) is set to release fourth-quarter earnings on Jan. 29, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 23 cents per share on revenues of $130.9 million.
Let us delve into the factors that might have influenced CLB’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.
Highlights of Q3 Earnings & Surprise History
In the last reported quarter, the Houston, TX-based oil and gas equipment and services company’s adjusted earnings beat the consensus mark. CLB reported adjusted earnings of 25 cents per share, which was 4 cents higher than the Zacks Consensus Estimate. This was attributed to robust performance from the Reservoir Description and Production Enhancement segments. Revenues of $134.4 million also beat the Zacks Consensus Estimate by 1.1%.
CLB’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed the remaining one, delivering an average surprise of 4.63% This is depicted in the graph below:
The Zacks Consensus Estimate for fourth-quarter 2024 earnings has remained unchanged in the past 30 days. The estimated figure indicates a 21.05% year-over-year increase. The Zacks Consensus Estimate for revenues indicates an increase of 2.10% from the year-ago period’s actual.
Factors to Consider Ahead of CLB’s Q4 Release
The company primarily makes money through its reservoir description and production enhancement services, which analyze and optimize oil and gas extraction processes.
CLB’s revenues are likely to have improved in the quarter to be reported. Our model predicts fourth-quarter revenues to increase to $130.9 million from the year-ago quarter’s level of $128.2 million. This can be attributed to the strong performance of the Reservoir Description segment, which is projected to increase 4.2% year over year, reaching $88.2 million.
On a bearish note, the increase in CLB’s costs might have dented its to-be-reported bottom line. The company’s fourth-quarter total operating expenses are likely to have been $115.2 million, up 1.3% from the year-ago quarter’s level. Moreover, its costs of services and product sales are expected to have increased from $101.5 million to $103.1 million in the same time frame. Its general and administrative expenses are expected to have increased from $8.7 million to $10.1 million in the same period.
This upward cost trend indicates the broader inflationary pressures in the economy, which could dampen the company's overall profitability despite the revenue gains.
What Does Our Model Say About CLB?
Our proven model does not predict an earnings beat for Core Laboratories this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.
CLB’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
CLB’s Zacks Rank: CLB currently carries a Zacks Rank #4 (Sell).
Stocks to Consider
Here are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
The firm is scheduled to release earnings on March 3. Notably, the Zacks Consensus Estimate for California’s 2025 earnings per share indicates 9.54% year-over-year growth. Valued at around $4.96 billion, CRC’s shares have risen 6.1% in a year.
Ovintiv (OVV - Free Report) has an Earnings ESP of +6.29% and a Zacks Rank #2. The firm is scheduled to release earnings on Feb. 26.
In the past 60 days, the Zacks Consensus Estimate for 2025 earnings has moved up 9.4%. Valued at around $11.82 billion, OVV’s shares have gained 9.6% in a year.
APACorporation (APA - Free Report) has an Earnings ESP of +6.10% and a Zacks Rank #2. The firm is scheduled to release earnings on Feb. 27.
In the past 60 days, the Zacks Consensus Estimate for 2025 earnings has increased 1%. Valued at around $8.64 billion, APA’s shares have lost 23.7% in a year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Core Laboratories to Post Q4 Earnings: Here's What to Expect
Core Laboratories Inc. (CLB - Free Report) is set to release fourth-quarter earnings on Jan. 29, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of 23 cents per share on revenues of $130.9 million.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Let us delve into the factors that might have influenced CLB’s performance in the to-be-reported quarter. Before that, it is worth taking a look at the company’s performance in the last reported quarter.
Highlights of Q3 Earnings & Surprise History
In the last reported quarter, the Houston, TX-based oil and gas equipment and services company’s adjusted earnings beat the consensus mark. CLB reported adjusted earnings of 25 cents per share, which was 4 cents higher than the Zacks Consensus Estimate. This was attributed to robust performance from the Reservoir Description and Production Enhancement segments. Revenues of $134.4 million also beat the Zacks Consensus Estimate by 1.1%.
CLB’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed the remaining one, delivering an average surprise of 4.63% This is depicted in the graph below:
Core Laboratories Inc. Price and EPS Surprise
Core Laboratories Inc. price-eps-surprise | Core Laboratories Inc. Quote
Trend in Estimate Revision for CLB Stock
The Zacks Consensus Estimate for fourth-quarter 2024 earnings has remained unchanged in the past 30 days. The estimated figure indicates a 21.05% year-over-year increase. The Zacks Consensus Estimate for revenues indicates an increase of 2.10% from the year-ago period’s actual.
Factors to Consider Ahead of CLB’s Q4 Release
The company primarily makes money through its reservoir description and production enhancement services, which analyze and optimize oil and gas extraction processes.
CLB’s revenues are likely to have improved in the quarter to be reported. Our model predicts fourth-quarter revenues to increase to $130.9 million from the year-ago quarter’s level of $128.2 million. This can be attributed to the strong performance of the Reservoir Description segment, which is projected to increase 4.2% year over year, reaching $88.2 million.
On a bearish note, the increase in CLB’s costs might have dented its to-be-reported bottom line. The company’s fourth-quarter total operating expenses are likely to have been $115.2 million, up 1.3% from the year-ago quarter’s level. Moreover, its costs of services and product sales are expected to have increased from $101.5 million to $103.1 million in the same time frame. Its general and administrative expenses are expected to have increased from $8.7 million to $10.1 million in the same period.
This upward cost trend indicates the broader inflationary pressures in the economy, which could dampen the company's overall profitability despite the revenue gains.
What Does Our Model Say About CLB?
Our proven model does not predict an earnings beat for Core Laboratories this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.
CLB’s Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
CLB’s Zacks Rank: CLB currently carries a Zacks Rank #4 (Sell).
Stocks to Consider
Here are some firms from the energy space that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
California Resources (CRC - Free Report) has an Earnings ESP of +2.59% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
The firm is scheduled to release earnings on March 3. Notably, the Zacks Consensus Estimate for California’s 2025 earnings per share indicates 9.54% year-over-year growth. Valued at around $4.96 billion, CRC’s shares have risen 6.1% in a year.
Ovintiv (OVV - Free Report) has an Earnings ESP of +6.29% and a Zacks Rank #2. The firm is scheduled to release earnings on Feb. 26.
In the past 60 days, the Zacks Consensus Estimate for 2025 earnings has moved up 9.4%. Valued at around $11.82 billion, OVV’s shares have gained 9.6% in a year.
APA Corporation (APA - Free Report) has an Earnings ESP of +6.10% and a Zacks Rank #2. The firm is scheduled to release earnings on Feb. 27.
In the past 60 days, the Zacks Consensus Estimate for 2025 earnings has increased 1%. Valued at around $8.64 billion, APA’s shares have lost 23.7% in a year.